MEDP
MEDP clinical trials: Medpace Holdings, Inc.
Every trial on ClinicalTrials.gov where Medpace Holdings, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 102
- Trials linked
- 0
- As lead sponsor
- 102
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MEDP on the catalyst calendar · MEDP registry changes
- Primary completion Mar 2029Sponsor estimatePhase 3NCT07605429BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.OHB Pediatrics Ltd. · Angelman SyndromeRecruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2028Sponsor estimatePhase 1/Phase 2NCT07432633[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsBlue Earth Diagnostics · Colorectal CancerRecruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2027Sponsor estimateNo phase registeredNCT07062471Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries...Shockwave Medical, Inc. · Carotid Artery CalcificationRecruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 30, 2023ActualPhase 3NCT04797104Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C ReductionLIB Therapeutics LLC · Heterozygous Familial HypercholesterolemiaCompletedMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 1/Phase 2NCT07189871177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsRadiopharm Theranostics, Ltd · Castration-Resistant Prostate Cancer (CRPC)RecruitingRADXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2032Sponsor estimateNo phase registeredNCT06564974Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMITCatalyst Pharmaceuticals, Inc. · Duchenne Muscular DystrophyRecruitingCPRXLeadICLRCollaboratorMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 7, 2026ActualPhase 2NCT05291091Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)Edgewise Therapeutics, Inc. · Becker Muscular DystrophyCompletedEWTXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2031Sponsor estimatePhase 2NCT06066580Open-Label Extension of EDG-5506 in Participants With Becker Muscular DystrophyEdgewise Therapeutics, Inc. · Becker Muscular DystrophyEnrolling by invitationEWTXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2028Sponsor estimatePhase 2NCT07702292[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsBlue Earth Diagnostics · Colorectal CancerRecruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 23, 2026ActualPhase 2NCT06777433Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesRadiopharm Theranostics, Ltd · Brain Metastases From Solid TumorsActive, not recruitingRADXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 1, 2024ActualPhase 3NCT03545607MultiStem® Administration for Stroke Treatment and Enhanced Recovery StudyHealios K.K. · Ischemic StrokeTerminatedMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimateNo phase registeredNCT07512128Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries...Shockwave Medical, Inc. · Carotid Artery CalcificationNot yet recruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2028Sponsor estimatePhase 3NCT07102511Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FHLIB Therapeutics LLC · Familial Hypercholesterolemia - HeterozygousEnrolling by invitationMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2026ActualPhase 3NCT05983250LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFTenax Therapeutics, Inc. · Pulmonary HypertensionActive, not recruitingTENXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 15, 2025ActualPhase 3NCT03073967Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus)...AiCuris Anti-infective Cures AG · HSV InfectionCompletedMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimatePhase 3NCT07614958Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults...A. Menarini International Licensing S.A. · Mixed DyslipidemiaRecruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 25, 2024ActualPhase 3NCT04979806Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)Wockhardt · Complicated Urinary Tract InfectionCompletedMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2027Sponsor estimatePhase 1/Phase 2NCT04329728The OPAL Study: AVM0703 for Treatment of Lymphoid MalignanciesAVM Biotechnology Inc · Lymphoid MalignanciesRecruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 25, 2023ActualPhase 2NCT03624010Open-Label Rollover Study of Levosimendan in PH-HFpEF PatientsTenax Therapeutics, Inc. · Hypertension Pulmonary Secondary Heart FailureCompletedTENXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2026Sponsor estimatePhase 2NCT05986851Azeliragon in MGMT Unmethylated GlioblastomaCantex Pharmaceuticals · GlioblastomaActive, not recruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2027Sponsor estimatePhase 3NCT07197580Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCCTelix Pharmaceuticals (Innovations) Pty Limited · ccRCCRecruitingMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2024ActualNo phase registeredNCT06160037Influence of Prenatal and Early Childhood Home-Visiting by Nurses on Development of Chronic DiseaseUniversity of Colorado, Denver · Chronic DiseaseCompletedMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 22, 2017ActualPhase 1NCT03340753Bioavailability of KBP-5074 Tablet vs Capsule FormulationsKBP Biosciences · BioequivalenceCompletedMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 15, 2025ActualEarly Phase 1NCT06516510A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative...Blue Earth Therapeutics Ltd · Metastatic Prostate CancerTerminatedMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 1, 2024ActualPhase 1NCT05160415A Study of EDG-5506 in Adult Males With Becker Muscular DystrophyEdgewise Therapeutics, Inc. · Becker Muscular DystrophyCompletedEWTXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 77 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner